Efficacy and Safety of EXPAREL Versus Standard of Care (SoC) in Subjects Undergoing Elective Cesarean Section

NCT03853694 · clinicaltrials.gov ↗

PHASE4

Phase

COMPLETED

Status

167

Enrollment

INDUSTRY

Sponsor class

Conditions

Elective Cesarean Section
Pain Management

Interventions

DRUG: 50 mcg Duramorph+ EXPAREL + multi-modal pain regimen
DRUG: 150 mcg Duramorph + multi-modal pain regimen
DRUG: Exparel TAP + multi-modal pain regimen

Sponsor

Pacira Pharmaceuticals, Inc